When was Sino Biological founded?

Sino Biological was founded in 2007 and raised its 1st funding round 10 years after it was founded.

Where is Sino Biological located?

Sino Biological is headquartered in Beijing, China.

How many employees does Sino Biological have?

As of Aug 31, 2026, the latest employee count at Sino Biological is 283.

Is Sino Biological a funded company?

Sino Biological is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 06, 2017.

When was the latest funding round of Sino Biological?

Sino Biological's latest funding was a $***** Series A round on Jul 06, 2017, with participation from 1 investor.

Where does Sino Biological rank among its competitors?

Sino Biological ranks 4th amongst 1259 active competitors, of which 76 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Sino Biological?

Sino Biological's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

Sino Biological - 2026 Company Profile, Funding & Competitors

Company Details

Provider of reagents and kits for clinical research. The product portfolio of the company includes recombinant proteins, antibodies, and antibody-based kits that are used to study cellular function and human diseases. Additionally, the company also offers services in custom antibody development, protein production, and purification.

Website: sinobiological.com
Social
Email ID: *****@sinobiological.com
Phone Number: +86 **********

Key Metrics

Founded Year

2007

Location

Beijing, China

Stage

Series A

Total Funding

$29.4M in 1 round

Latest Funding Round

Series A, Jul 06, 2017, $*****

Investors

Qiming Venture Partners & 2 more

Ranked

4^th among 1259 active competitors

Employee Count

283 as on Aug 31, 2026

Investment & Acquisitions

SignalChem & 1 more

Similar Companies

Enzo & 632 more

View Sino Biological's full profile

Sino Biological has raised a total funding of $29.4M over 1 round. Its latest funding round was a Series A round on Jul 06, 2017 for $*****. 1 investor participated in its latest round. Sino Biological has 3 institutional investors.

Here is the list of recent funding rounds of Sino Biological:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 06, 2017	8884033	Series A	6151193	5092850	8138298	4773205

Access funding benchmarks and valuations. Sign up today!

View details of Sino Biological's funding rounds and investors

Sino Biological's employee count trend

Sino Biological has 283 employees as of Aug 26. Here is Sino Biological's employee count trend over the years:

Employee count trend for Sino Biological

Uncover Sino Biological's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sino Biological include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of Sino Biological, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
8th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Thompson Street Capital Partners ... & 4 others	56/100
10th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100